Machine learning

AI is enabling the development of a next generation of drugs that can more precisely target cancer cells while sparing healthy tissues.

Artificial intelligence won’t replace people in biopharma, but it is infiltrating every step of drug development, including in some ways that aren’t so obvious.

The insights AI affords can potentially boost sustainability, but it’s unclear whether these gains outweigh the technology’s environmental cost.